Anti flu vaccine: alarming decrease in coverage of the categories at risk (18-64 years)
D'Argenzio, A.; Ferrante, G.; Baldissera, S.; Bella, A.; Minardi, V.; Possenti, V.; Quarchioni, E.; Masocco, M.; Salmaso, S.
Epidemiologia e Prevenzione 38(2): 146
2014
ISSN/ISBN: 1120-9763 PMID: 24986417 Document Number: 677192
Document emailed within 1 workday
Related Documents
Vázquez Fernández, E.; López Rois, F.; Vázquez Carrete, J.A.; Gómez Tato, B.; Alvarez Ares, M. 1987: Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old Anales Espanoles de Pediatria 27(1): 27-31Litt, J.C.; Lake, P.B. 1993: Improving influenza vaccine coverage in at-risk groups. Good intentions are not enough Medical Journal of Australia 159(8): 542-547
Wang, P.G.; Zhang, X.S.; An, J.; Wang, X.X.; Zhang, N.J.; Tang, Y.; Wang, X.L.; Liang, X.F.; Zhang, B.L.; Jiao, Y.Z.; Bao, J.Y.; Deng, L.; Li, X.B.; Li, H. 2016: Investigation and analysis of the coverage rate of hepatitis B vaccine in Gansu province after 12 years since integrated into expanded programme on immunization Zhonghua Yu Fang Yi Xue Za Zhi 50(6): 541-543
Benamouzig, R. 1998: Do aspirin or nonsteroidal anti-inflammatory drugs decrease the risk of colorectal cancer? Gastroenterologie Clinique et Biologique 22(3 Suppl): S22-S27
Kurl, A.; Berry, V.; Dhanoa, J.; Masih, A. 2007: Seropositivity of HBsAg, anti HCV and anti HIV among blood donors: a comparative study on three years of 5 years interval Indian journal of public health 51(1): 41-42
Dini, E.F.; Chaney, M.; Moolenaar, R.L.; LeBaron, C.W. 1996: Information as intervention: how Georgia used vaccination coverage data to double public sector vaccination coverage in seven years Journal of Public Health Management and Practice: Jphmp 2(1): 45-49
Kaplan, R.L.; Sevelius, J.; Ribeiro, K. 2016: In the name of brevity: The problem with binary HIV risk categories Global Public Health 11(7-8): 824-834
Lukka, H. 2002: Prostate cancer: risk categories and role of hormones and radiotherapy Canadian Journal of Urology 9(Suppl 1): 26-29
Lytkina, I.N.; Filatov, N.N.; Mironova, V.F.; Solodovnikov, I.P. 2001: Measles: prospects of vaccine prophylaxis and decrease of morbidity in Moscow Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 25-28
Bolanda, D.; Talani, P.; Nzaba, P.; Moudzeo, H.; Biahoua, M.; Mayanda, H.; Yala, F. 2000: Survey of measles vaccine coverage in Brazzaville Bulletin de la Societe de Pathologie Exotique 93(2): 123-124
Padayachee, N.; Hurwitz, H.S.; Vlok, A.; de Souza, C. 1990: Poliomyelitis vaccine coverage in south-western Johannesburg South African Medical Journal 77(3): 166-167
Osaki, A.; Saeki, T. 2007: Future direction of adjuvant chemotherapy for breast cancer following new risk categories of St. Gallen Consensus Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 6: 407-413
Deshmukh, U.S.; Talwar, G.P.; Gupta, S.K. 1994: IgG subclass distribution of anti-hCG and anti-diphtheria toxoid antibodies in women immunized with a beta-hCG based immunocontraceptive vaccine Journal of Reproductive Immunology 26(1): 65-72
Hahn, H.L.; Mössner, J. 1980: Influenza vaccination of risk patients with trivalent split virus vaccine and subunit vaccine Münchener Medizinische Wochenschrift 122(42): 1477-1480
Martínez Adell, M.A.; Vives Argilagós, A.; Sibera Aresté, F.X.; Navarrete Durán, P.; Barro Lugo, S.; Urbina García, P. 2003: Epidemiological study of the hepatitis C virus in our population and vaccine coverage Atencion Primaria 31(7): 428-432
Merlin, M.; Josse, R.; Josseran, R.; Owona-Essomba, R.; Ghogomu, A.; Sanokho, S.; Kouka Bemba, D. 1988: Impact of the African year of vaccination on vaccine coverage in Cameroon Medecine Tropicale: Revue du Corps de Sante Colonial 48(3): 259-261
Olshen, E.; Mahon, B.E.; Wang, S.; Woods, E.R. 2007: The impact of state policies on vaccine coverage by age 13 in an insured population Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 40(5): 405-411
Kihm, U. 1976: Comparison of a bivalent anti-foot-and-mouth disease vaccine with oil adjuvant to a vaccine with DEAE-dextran adjuvant in swine Developments in Biological Standardization 35: 149-153
Travasso, C. 2015: Better surveillance and vaccine coverage are needed to eliminate measles in India by 2020 Bmj 350: H900
Mravian, S.R.; Grigor'eva, N.M. 1994: Ischemic heart disease risk factors in several categories of mental work employees and industrial workers (review of the literature) Meditsina Truda i Promyshlennaia Ekologiia 1994(2): 27-32